InsidersTradesSigma
Explore the detailed record of transactions filed by Jeppe Øvli Øvlesen, Chief Executive Officer. Insider active across 2 companies, notably SynAct Pharma AB. In total, 1 filings have been published. History available since 5 March 2026. The latest transaction was disclosed on 5 March 2026 (Purchase). Regulator: FIN-FSA. All data is openly available.
1 of 1 declaration
Jeppe Øvli Øvlesen is the Chief Executive Officer of SynAct Pharma AB, a biopharmaceutical company. In his role, he is responsible for the strategic direction of the company and managing operations. Jeppe Øvli Øvlesen is committed to developing innovative treatments and improving patients' lives through SynAct Pharma's solutions.